Cargando…
Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction
A new coronavirus called SARS-CoV-2 is rapidly spreading around the world. Over 16,558,289 infected cases with 656,093 deaths have been reported by July 29th, 2020, and it is urgent to identify effective antiviral treatment. In this study, potential antiviral drugs against SARS-CoV-2 were identified...
Autores principales: | Peng, Lihong, Tian, Xiongfei, Shen, Ling, Kuang, Ming, Li, Tianbao, Tian, Geng, Yang, Jialiang, Zhou, Liqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525008/ https://www.ncbi.nlm.nih.gov/pubmed/33193695 http://dx.doi.org/10.3389/fgene.2020.577387 |
Ejemplares similares
-
Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures
por: Peng, Lihong, et al.
Publicado: (2021) -
Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method
por: Zhou, Liqian, et al.
Publicado: (2020) -
Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization
por: Wang, Juanjuan, et al.
Publicado: (2021) -
Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022) -
Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)